Almac Diagnostics

Development of genomics solutions for the advancement of science and the improvement of patient care

Almac Diagnostics belongs to the Almac Group headquartered in Craigavon, Northern Ireland with facilities in the UK and USA.

Alan Armstrong (Group CEO)
John Irvine (Director Commercial Development)
Richard Milliken (Group Financial Director)
Paul Harkin (President & Managing Director, Almac Diagnostics)

Sir Allen McClay (Chairman)

Diagnostics
19 Seagoe Industrial Estate
Craigavon BT63 5QD
United Kingdom
Phone: +44-28-3833-7575
Fax: +44-28-3839-8676

Cancer DSA™ research tools are the first high-density transcriptome based microarrays that focus on the transcriptome of a particular disease.